New York Life Trust’s Celgene Corp CELG Stock Holding History

New York Life Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$0	Sell	4 -50	-93%	-$5.98K	﹤0.01%	255
2016 Q4	$6K	Buy	54 +40	+286%	+$4.46K	0.03%	202
2016 Q3	$1K	Buy	+14	New	+$1.51K	﹤0.01%	219
2016 Q2	–	Sell	-24	Closed	-$2K	–	311
2016 Q1	$2K	Sell	24 -56	-70%	-$5.77K	0.01%	250
2015 Q4	$10K	Sell	80 -653	-89%	-$75.5K	0.04%	200
2015 Q3	$79K	Sell	733 -450	-38%	-$55.8K	0.35%	112
2015 Q2	$137K	Sell	1,183 -557	-32%	-$63.7K	0.57%	54
2015 Q1	$201K	Buy	1,740 +1,488	+590%	+$178K	0.8%	33
2014 Q4	$28K	Buy	+252	New	+$26.6K	0.11%	166
2014 Q2	–	Sell	-68	Closed	-$5K	–	240
2014 Q1	$5K	Sell	68 -400	-85%	-$31.7K	0.02%	188
2013 Q4	$40K	Sell	468 -1,892	-80%	-$150K	0.18%	157
2013 Q3	$182K	Sell	2,360 -498	-17%	-$34.9K	0.91%	30
2013 Q2	$167K	Buy	+2,858	New	+$172K	0.77%	33

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New York Life Trust's CELG Position: Q1 2017 in Review

New York Life Trust reduced its Celgene Corp (CELG) stake by 93% in Q1 2017, selling an estimated $5.98K and leaving 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #255.

New York Life Trust first reported a position in CELG in Q2 2013 and has held it in 13 quarters since. The position peaked at $201K in Q1 2015. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

New York Life Trust held 4 shares of Celgene Corp worth $0 as of Q1 2017.
New York Life Trust sold 50 Celgene Corp shares in Q1 2017, an estimated $5.98K.
Celgene Corp made up ﹤0.01% of New York Life Trust's portfolio in Q1 2017, its #255 holding.
New York Life Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 13 quarters since.
New York Life Trust's Celgene Corp position peaked at $201K in Q1 2015.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.